|
Gene: ANKH |
Gene summary for ANKH |
Gene summary. |
Gene information | Species | Human | Gene symbol | ANKH | Gene ID | 56172 |
Gene name | ANKH inorganic pyrophosphate transport regulator | |
Gene Alias | ANK | |
Cytomap | 5p15.2 | |
Gene Type | protein-coding | GO ID | GO:0001501 | UniProtAcc | Q9HCJ1 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
56172 | ANKH | P128T-E | Human | Esophagus | ESCC | 5.06e-11 | 3.39e-01 | 0.1241 |
56172 | ANKH | P130T-E | Human | Esophagus | ESCC | 3.03e-58 | 1.18e+00 | 0.1676 |
56172 | ANKH | NAFLD1 | Human | Liver | NAFLD | 1.58e-08 | 6.45e-01 | -0.04 |
56172 | ANKH | S43 | Human | Liver | Cirrhotic | 1.36e-03 | -1.39e-01 | -0.0187 |
56172 | ANKH | HCC1_Meng | Human | Liver | HCC | 1.28e-47 | -1.34e-01 | 0.0246 |
56172 | ANKH | HCC2_Meng | Human | Liver | HCC | 9.30e-16 | -1.15e-01 | 0.0107 |
56172 | ANKH | cirrhotic1 | Human | Liver | Cirrhotic | 3.15e-02 | -2.18e-01 | 0.0202 |
56172 | ANKH | HCC1 | Human | Liver | HCC | 4.46e-12 | 3.30e+00 | 0.5336 |
56172 | ANKH | HCC2 | Human | Liver | HCC | 1.54e-20 | 3.72e+00 | 0.5341 |
56172 | ANKH | HCC5 | Human | Liver | HCC | 7.49e-04 | 1.97e+00 | 0.4932 |
56172 | ANKH | S014 | Human | Liver | HCC | 8.76e-07 | 4.01e-01 | 0.2254 |
56172 | ANKH | S015 | Human | Liver | HCC | 2.91e-06 | 4.62e-01 | 0.2375 |
56172 | ANKH | S016 | Human | Liver | HCC | 2.27e-07 | 3.14e-01 | 0.2243 |
56172 | ANKH | S027 | Human | Liver | HCC | 3.43e-02 | 1.72e-01 | 0.2446 |
56172 | ANKH | S028 | Human | Liver | HCC | 1.01e-05 | 4.29e-01 | 0.2503 |
56172 | ANKH | S029 | Human | Liver | HCC | 3.29e-02 | 3.41e-01 | 0.2581 |
56172 | ANKH | C04 | Human | Oral cavity | OSCC | 6.23e-15 | 8.91e-01 | 0.2633 |
56172 | ANKH | C30 | Human | Oral cavity | OSCC | 5.15e-40 | 1.45e+00 | 0.3055 |
56172 | ANKH | C38 | Human | Oral cavity | OSCC | 8.31e-12 | 1.31e+00 | 0.172 |
56172 | ANKH | C43 | Human | Oral cavity | OSCC | 2.24e-19 | 3.87e-01 | 0.1704 |
Page: 1 2 3 4 5 6 7 8 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0015698 | Colorectum | AD | inorganic anion transport | 52/3918 | 180/18723 | 6.83e-03 | 4.22e-02 | 52 |
GO:0001503 | Colorectum | AD | ossification | 106/3918 | 408/18723 | 7.68e-03 | 4.64e-02 | 106 |
GO:00015031 | Colorectum | SER | ossification | 82/2897 | 408/18723 | 6.76e-03 | 4.78e-02 | 82 |
GO:00015033 | Colorectum | FAP | ossification | 79/2622 | 408/18723 | 1.53e-03 | 1.37e-02 | 79 |
GO:0030278 | Colorectum | FAP | regulation of ossification | 27/2622 | 115/18723 | 4.23e-03 | 2.90e-02 | 27 |
GO:00156981 | Colorectum | FAP | inorganic anion transport | 38/2622 | 180/18723 | 5.73e-03 | 3.67e-02 | 38 |
GO:00015034 | Colorectum | CRC | ossification | 64/2078 | 408/18723 | 2.73e-03 | 2.49e-02 | 64 |
GO:000150317 | Esophagus | ESCC | ossification | 232/8552 | 408/18723 | 3.00e-06 | 3.40e-05 | 232 |
GO:00015035 | Liver | Cirrhotic | ossification | 127/4634 | 408/18723 | 1.89e-03 | 1.19e-02 | 127 |
GO:000150310 | Oral cavity | OSCC | ossification | 203/7305 | 408/18723 | 5.54e-06 | 6.19e-05 | 203 |
GO:000150315 | Oral cavity | LP | ossification | 123/4623 | 408/18723 | 6.55e-03 | 3.84e-02 | 123 |
GO:00015039 | Prostate | BPH | ossification | 107/3107 | 408/18723 | 4.31e-07 | 8.83e-06 | 107 |
GO:00302782 | Prostate | BPH | regulation of ossification | 29/3107 | 115/18723 | 1.18e-02 | 4.76e-02 | 29 |
GO:000150314 | Prostate | Tumor | ossification | 109/3246 | 408/18723 | 1.13e-06 | 2.14e-05 | 109 |
GO:003027811 | Prostate | Tumor | regulation of ossification | 32/3246 | 115/18723 | 3.39e-03 | 1.75e-02 | 32 |
GO:0001503110 | Thyroid | PTC | ossification | 176/5968 | 408/18723 | 9.26e-07 | 1.40e-05 | 176 |
GO:00302785 | Thyroid | PTC | regulation of ossification | 51/5968 | 115/18723 | 3.30e-03 | 1.61e-02 | 51 |
GO:000150332 | Thyroid | ATC | ossification | 206/6293 | 408/18723 | 9.23e-13 | 3.95e-11 | 206 |
GO:003027813 | Thyroid | ATC | regulation of ossification | 60/6293 | 115/18723 | 3.01e-05 | 2.51e-04 | 60 |
GO:01101492 | Thyroid | ATC | regulation of biomineralization | 45/6293 | 99/18723 | 9.34e-03 | 3.44e-02 | 45 |
Page: 1 2 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ANKH | SNV | Missense_Mutation | c.563N>T | p.Glu188Val | p.E188V | Q9HCJ1 | protein_coding | deleterious(0.01) | probably_damaging(0.997) | TCGA-A8-A06Z-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ANKH | SNV | Missense_Mutation | rs142872069 | c.668N>T | p.Arg223Ile | p.R223I | Q9HCJ1 | protein_coding | tolerated(0.13) | benign(0.053) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ANKH | SNV | Missense_Mutation | c.1118N>A | p.Ile373Asn | p.I373N | Q9HCJ1 | protein_coding | deleterious(0) | possibly_damaging(0.467) | TCGA-B6-A0WS-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ANKH | SNV | Missense_Mutation | c.383N>T | p.Thr128Met | p.T128M | Q9HCJ1 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-BH-A18L-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
ANKH | insertion | Frame_Shift_Ins | novel | c.1408_1409insGT | p.Ser470CysfsTer4 | p.S470Cfs*4 | Q9HCJ1 | protein_coding | TCGA-A2-A0D4-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD | ||
ANKH | insertion | In_Frame_Ins | novel | c.1406_1407insAAGAAAAAGGCAGGCCCTTTGTGTCTACCGTTTTCAGTG | p.Asp469delinsGluArgLysArgGlnAlaLeuCysValTyrArgPheGlnCys | p.D469delinsERKRQALCVYRFQC | Q9HCJ1 | protein_coding | TCGA-A2-A0D4-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD | ||
ANKH | insertion | In_Frame_Ins | novel | c.1142_1143insGCCACTTCAATA | p.Val381_Thr382insProLeuGlnTyr | p.V381_T382insPLQY | Q9HCJ1 | protein_coding | TCGA-AN-A0FS-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
ANKH | SNV | Missense_Mutation | novel | c.1318G>C | p.Glu440Gln | p.E440Q | Q9HCJ1 | protein_coding | deleterious(0) | probably_damaging(0.968) | TCGA-EK-A2RJ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
ANKH | SNV | Missense_Mutation | c.851N>A | p.Pro284His | p.P284H | Q9HCJ1 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-A6-3809-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ANKH | SNV | Missense_Mutation | c.1154C>T | p.Ala385Val | p.A385V | Q9HCJ1 | protein_coding | deleterious(0) | probably_damaging(0.97) | TCGA-AA-3977-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |